Results 161 to 170 of about 61,737 (200)

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV

open access: yesNew England Journal of Medicine, 2014
Peter Ferenci   +2 more
exaly   +2 more sources

Inhibition of cardiomyocyte differentiation of human induced pluripotent stem cells by Ribavirin: Evidence for its cardiac developmental toxicity.

Toxicology, 2020
Ribavirin has been proven to be an antiviral treatment, whereas there are still risks of hemolysis and congenital malformation. Abnormal cardiac development contributes to the occurrence and development of many heart diseases. However, there is so far no
Danyu Ye   +19 more
semanticscholar   +1 more source

The Use of Ribavirin as an Anticancer Therapeutic: Will It Go Viral?

Molecular Cancer Therapeutics, 2019
The growing cost of medical care worldwide, particularly in oncology, has incentivized researchers and physicians to repurpose clinically used drugs to alleviate the financial burden of drug development and offer potential new therapeutics.
Joshua Casaos   +12 more
semanticscholar   +1 more source

Ribavirin for Treatment of Subjects with Respiratory Syncytial Virus-Related Infection: A Systematic Review and Meta-Analysis

Advances in Therapy, 2022
Sofía Tejada   +5 more
semanticscholar   +1 more source

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

Annals of Internal Medicine, 2004
S. Hadziyannis   +13 more
semanticscholar   +1 more source

IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy

Nature Genetics, 2009
V. Suppiah   +18 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy